Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase

Sleep. 2004 Aug 1;27(5):857-65. doi: 10.1093/sleep/27.5.857.

Abstract

Study objectives: Oleamide and anandamide are fatty acid amides implicated in the regulatory mechanisms of sleep processes. However, due to their prompt catabolism by fatty acid amide hydrolase (FAAH), their pharmacologic and behavioral effects, in vivo, disappear rapidly. To determine if, in the absence of FAAH, the hypnogenic fatty acid amides induce an increase of sleep, we characterized the sleep-wake patters in FAAH-knockout mice [FAAH (-/-)] before and after sleep deprivation.

Design: FAAH (-/-), FAAH (+/-), and FAAH (+/+) mice were implanted chronically for sleep, body temperature (Tb), and locomotor activity (LMA) recordings. Sleep-wake states were recorded during a 24-hour baseline session followed by 8 hours of sleep deprivation. Recovery recordings were done during the 16 hours following sleep deprivation. Total amount of wake, slow-wave sleep, and rapid eye movement sleep were calculated and compared between genotypes. The electroencephalographic spectral analysis was performed by fast Fourier transform analysis. Telemetry recordings of Tb and LMA were carried out continuously during 4 days under baseline conditions.

Setting: N/A.

Patients or participants: FAAH (-/-) mice and their heterozygote (+/-) and control (+/+) littermates were used.

Interventions: Sleep deprivation.

Measurements and results: FAAH (-/-) mice possess higher values of slow-wave sleep and more intense episodes of slow-wave sleep than do control littermates under baseline conditions that are not related to differences in Tb and LMA. A rebound of slow-wave sleep and rapid eye movement sleep as well an increase in the levels of slow-wave activity were observed after sleep deprivation in all genotypes.

Conclusion: These findings support the role of fatty acid amides as possible modulators of sleep and indicate that the homeostatic mechanisms of sleep in FAAH (-/-) mice are not disrupted.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amidohydrolases / deficiency
  • Amidohydrolases / genetics
  • Amidohydrolases / physiology*
  • Animals
  • Arachidonic Acids / administration & dosage
  • Arachidonic Acids / analysis
  • Arachidonic Acids / pharmacology
  • Arousal / drug effects
  • Behavior, Animal / drug effects
  • Brain / drug effects
  • Brain Chemistry
  • Electroencephalography
  • Endocannabinoids
  • Genotype
  • Hypnotics and Sedatives / administration & dosage
  • Hypnotics and Sedatives / analysis
  • Hypnotics and Sedatives / pharmacology
  • Mice
  • Mice, Knockout
  • Oleic Acids / administration & dosage
  • Oleic Acids / analysis
  • Oleic Acids / pharmacology
  • Polyunsaturated Alkamides
  • Sleep Deprivation / metabolism*
  • Sleep, REM / drug effects
  • Sleep, REM / physiology*
  • Time Factors
  • Wakefulness / drug effects
  • Wakefulness / physiology*

Substances

  • Arachidonic Acids
  • Endocannabinoids
  • Hypnotics and Sedatives
  • Oleic Acids
  • Polyunsaturated Alkamides
  • oleylamide
  • Amidohydrolases
  • fatty-acid amide hydrolase
  • anandamide